ONCT - Oncternal Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ONCT is currently covered by 4 analysts with an average price target of $15.87. This is a potential upside of $14.73 (1292.11%) from yesterday's end of day stock price of $1.14.

Oncternal Therapeutics's activity chart (see below) currently has 2 price targets and 17 ratings on display. The stock rating distribution of ONCT is 61.54% BUY and 38.46% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 22.86% with an average time for these price targets to be met of 40.6 days.

Highest price target for ONCT is $18, Lowest price target is $2, average price target is $15.87.

Most recent stock forecast was given by RAGHURAM SELVARAJU from HC WAINWRIGHT on 12-Aug-2024. First documented stock forecast 10-Aug-2020.

Best performing analysts who are covering ONCT - Oncternal Therapeutics:

Hartaj Singh Li Watsek Raghuram Selvaraju Naureen Quibria Kemp Dolliver

Currently out of the existing stock ratings of ONCT, 8 are a BUY (61.54%), 5 are a HOLD (38.46%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$18

$16.86 (1478.95%)

$19

3 months 12 days ago
(12-Aug-2024)

1/7 (14.29%)

$13.83 (331.65%)

190

Buy

$2

$-5.6 (-73.68%)

11 months 21 days ago
(04-Dec-2023)

0/1 (0%)

$-5 (-71.43%)

Hold

$26

$24.86 (2180.70%)

1 years 2 months 17 days ago
(07-Sep-2023)

0/2 (0%)

$20 (333.33%)

Hold

$70

1 years 7 months 20 days ago
(04-Apr-2023)

0/1 (0%)

$50 (250.00%)

Hold

$9

1 years 7 months 21 days ago
(04-Apr-2023)

1/1 (100%)

$-5.2 (-36.62%)

13

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ONCT (Oncternal Therapeutics) average time for price targets to be met?

On average it took 40.6 days on average for the stock forecasts to be realized with a an average price target met ratio 22.86

Which analyst has the current highest performing score on ONCT (Oncternal Therapeutics) with a proven track record?

HARTAJ SINGH

Which analyst has the current lower performing score on ONCT (Oncternal Therapeutics) with a proven track record?

KEMP DOLLIVER

Which analyst has the most public recommendations on ONCT (Oncternal Therapeutics)?

Hartaj Singh works at OPPENHEIMER and has 24 price targets and 12 ratings on ONCT

Which analyst is the currently most bullish on ONCT (Oncternal Therapeutics)?

Li Watsek with highest potential upside - $24.86

Which analyst is the currently most reserved on ONCT (Oncternal Therapeutics)?

Kemp Dolliver with lowest potential downside - -$5.6

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?